ORGANOGENESIS HOLDINGS INC. Earnings Per Share (Basic)
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Earnings Per Share (Basic) of -$0.77 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.77.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.44.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.28, a 510.78% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.11, a 22.22% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for fiscal 2025 was $0.16.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for fiscal 2024 was -$0.01, a 125.00% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for fiscal 2023 was $0.04, a 66.67% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic for fiscal 2022 was $0.12, a 83.56% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.77 10-Q · filed 2026-08-06 | -$1.21 10-Q · filed 2026-08-06 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | -$0.44 10-Q · filed 2026-05-07 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | $0.28 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.39 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.30 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.16 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.11 10-Q · filed 2025-11-06 | $0.02 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.12 10-Q · filed 2025-11-06 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$0.10 10-Q · filed 2026-08-06 | -$0.27 10-Q · filed 2026-08-06 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-03-31 | -$0.17 10-Q · filed 2026-05-07 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-05-07 | ||
| 2024-12-31 | $0.05 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.14 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.01 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.01 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.09 10-Q · filed 2025-11-06 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.05 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$0.13 10-Q · filed 2025-08-07 | -$0.14 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | -$0.02 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | $0.04 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $0.02 10-Q · filed 2024-11-12 | $0.04 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | $0.04 10-Q · filed 2024-08-08 | $0.02 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | -$0.02 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | $0.12 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.06 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $0.07 10-Q · filed 2023-08-09 | $0.06 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | -$0.01 10-Q · filed 2023-05-10 | $0.00 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | $0.73 10-K · filed 2024-02-29 | $0.74 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $0.10 10-Q · filed 2022-11-09 | $0.34 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | $0.16 10-Q · filed 2022-08-09 | $0.24 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | $0.08 10-Q · filed 2022-05-10 | |||||
| 2020-12-31 | $0.15 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.35 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.16 10-K · filed 2023-03-01 | $0.17 10-K · filed 2021-03-16 | ||
| 2020-09-30 | $0.20 10-Q · filed 2021-11-09 | -$0.01 10-Q · filed 2021-11-09 | ||||
| 2020-06-30 | -$0.05 10-Q · filed 2021-08-09 | -$0.21 10-Q · filed 2021-08-09 | ||||
| 2020-03-31 | -$0.16 10-Q · filed 2021-05-11 | |||||
| 2019-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$0.15 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$0.42 10-K · filed 2022-03-01 | -$0.44 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$0.12 10-Q · filed 2020-11-09 | -$0.40 10-Q · filed 2020-11-09 | ||||
| 2018-12-31 | -$0.94 10-K · filed 2021-03-16 | |||||
| 2017-12-31 | -$0.07 10-K · filed 2019-03-18 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.14 derived: net income ÷ weighted average shares · filed 2020-03-09 | ||
| 2017-09-30 | -$0.08 10-K · filed 2019-03-18 | -$0.05 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$0.05 derived: net income ÷ weighted average shares · filed 2019-03-18 | |||
| 2017-06-30 | $0.00 10-K · filed 2019-03-18 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-03-18 | ||||
| 2017-03-31 | $0.02 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |